PherDal Fertility Science, Inc.

PherDal is developing the first FDA-cleared, at-home fertility treatment. Our patented sterile technology brings assisted reproduction back into the home as an affordable, over-the-counter fertility treatment. After 16 months of unexplained infertility, our founder used her Ph.D. in Biology and her husband’s mechanical engineering skills to invent a medical device that conceived their daughter in the second month. PherDal’s 200 proof-of-concept kits sold out in 90 days, with 34 reported pregnancies. PherDal is working to become the first FDA-cleared over-the-counter infertility treatment offered without a prescription. Their crowdfunding equity campaign raised over $630K. Most recently Dr. Jenn was featured as SXSW Pitch finalist and innovation speaker at LSI’s Emerging Medtech conference in 2023. PherDal anticipates bringing its groundbreaking patented device to market in 2023!